Evidence map›Paper›PMID 36685321›Full record

Article3 Biotech2023

Genome sequence of

Alba Lara-Moreno, Esmeralda Morillo, Francisco Merchán, Jose Luis Gonzalez-Pimentel, Jaime Villaverde

Open access · greenAbstract readCase Reports
In one paragraph

Article in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Biodegradation of Phenanthrene byMicroorganisms · 2025
    Article
  2. Draft genome sequences of fiveMicrobiology resource announcements · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Alba Lara-MorenoInstitute of Natural Resources and Agrobiology of Seville, Department of Agrochemistry, Environmental Microbiology and Soil Conservation, Spanish National Research Council (IRNAS-CSIC), Seville, Spain.ORCID 0000-0002-5741-7662
Esmeralda MorilloInstitute of Natural Resources and Agrobiology of Seville, Department of Agrochemistry, Environmental Microbiology and Soil Conservation, Spanish National Research Council (IRNAS-CSIC), Seville, Spain.
Francisco MerchánDepartment of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville, Seville, Spain.
Jose Luis Gonzalez-PimentelAndalusian Centre for Developmental Biology (CABD, UPO-CSIC-JA), Faculty of Experimental Sciences (Genetics Department), University Pablo de Olavide, 41013 Seville, Spain.
Jaime VillaverdeInstitute of Natural Resources and Agrobiology of Seville, Department of Agrochemistry, Environmental Microbiology and Soil Conservation, Spanish National Research Council (IRNAS-CSIC), Seville, Spain.
Consejo Superior de Investigaciones Científicas · ESCentro Andaluz de Biología del Desarrollo · ESUniversidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental pollution caused by polycyclic aromatic hydrocarbons (PAHs) involves a high-risk and have received considerable attention due to their carcinogenic, teratogenic, and mutagenic properties. Phenanthrene (PHE) is a low molecular weight PAH, which has three benzene rings. It is one of the most common PAH found in contaminated environments mainly due to its low volatilization ability and hydrophobic character. A PHE degrading bacterium was isolated from an industrial contaminated soil using enrichment culture techniques. Based on macroscopic, microscopic examination and phylogenetic analysis, this bacterium was classified as

Indexed as

Degrading-bacteriumPhenanthrenePolycyclic aromatic hydrocarbonsStenotrophomonas indicatrixWhole genome sequence

Identifiers

PMID36685321
PMCPMC9849604
OpenAlexW4317207115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.